NCI budget: a “Yes” to one thing means a “No” to something else, director says.
Also in this 8-page issue: Bush nominates McClellan to head CMS.
FDA to refer false statements by regulated companies to SEC.
Sandra Horning elected ASCO president-elect.
Medicare coverage and quality of care top ASCO’s list of policy priorities for 2004.
NIH appoints panel to review conflict of interest rules.
Funding opportunities listed.
PDF file includes 8-page February issue of Business & Regulatory Report.
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
